In this context, the expression levels of NLRP3 and IL-1β are increased in the VAT of obese patients with metabolic alterations when compared with obese patients without these alterations [85], suggesting that the NLRP3 inflammasome has an important role in metabolic alterations associated with obesity [86]. The gene discussed is NLRP3; the disease is Obesity.